Can Hormone Replacement Therapy Make Ovarian Cysts Worse?

Hormone replacement therapy (HRT) does not typically cause ovarian cysts, but the relationship is more complex than a simple yes or no. For most women, HRT does not make existing ovarian cysts worse, and in some cases, it may actually reduce their formation. However, certain types of HRT and specific cyst types require careful monitoring, especially in the first year of treatment.

What Are Ovarian Cysts and Why Do They Form?

Ovarian cysts are fluid-filled sacs that develop on or inside an ovary. Most are harmless and disappear on their own within a few months. They are incredibly common — most women will develop at least one during their reproductive years.

The most frequent type is a functional cyst, which forms during the normal menstrual cycle. A follicle that fails to release an egg becomes a follicular cyst. A follicle that releases the egg but then seals off and fills with fluid becomes a corpus luteum cyst. Both are driven by the natural rise and fall of estrogen and progesterone.

Because these cysts depend on cyclical hormone surges, they typically stop forming when a woman enters menopause and hormone levels drop. This is why HRT is sometimes questioned — it reintroduces hormones that could theoretically stimulate cyst growth.

Can Hormone Replacement Therapy Make Ovarian Cysts Worse?

The short answer is no for most women, but yes in specific circumstances. Standard HRT doses are much lower than the natural hormone levels during a menstrual cycle. For this reason, HRT rarely triggers new functional cyst formation in postmenopausal women.

However, the picture changes depending on the type of HRT. Estrogen-only therapy can sometimes stimulate the ovarian tissue that remains after menopause. This is particularly relevant for women who still have their ovaries and are using systemic estrogen. Some research suggests these women may develop simple cysts during the first year of treatment, though most cysts remain small and harmless.

Combined HRT — estrogen plus progestogen — appears to carry a lower risk of cyst formation. The progestogen component counterbalances estrogen’s growth-promoting effects on ovarian tissue. For postmenopausal women, the absolute risk remains low regardless of the regimen chosen.

How Different Types of HRT Affect the Ovaries

The way HRT affects the ovaries depends heavily on the delivery method and the hormones used. Systemic HRT — pills, patches, or gels — circulates hormones throughout the body and can reach the ovaries. Local vaginal estrogen, such as creams or rings, is absorbed minimally into the bloodstream and has no meaningful effect on the ovaries.

Bioidentical hormones are sometimes marketed as safer alternatives, but the evidence does not support this claim. The term “bioidentical” refers to hormones chemically identical to those the body produces. Both bioidentical and synthetic hormones can affect ovarian tissue similarly. No large human trials have confirmed that bioidentical HRT carries a lower cyst risk than conventional HRT.

Tibolone, a synthetic steroid used in some countries for menopause symptoms, has a different profile. Some studies suggest it may slightly increase the risk of benign ovarian cysts compared with traditional HRT. The evidence here is limited, and the absolute risk remains small.

What the Research Actually Shows

Clinical studies on HRT and ovarian cysts have produced mixed but generally reassuring results. Large observational studies have not found a consistent link between HRT use and an increased risk of ovarian cysts in postmenopausal women. When cysts do appear, they are usually simple cysts that resolve without intervention.

One area of genuine concern involves women who are perimenopausal — the transition years before menopause. These women still have natural cycles, and adding HRT can create unpredictable hormone patterns. In this group, functional cysts may form more readily, though the evidence is not definitive.

Research published in menopause-focused journals has consistently found that most cysts discovered during HRT use are benign. Malignant transformation of a simple cyst is extremely rare. The bigger clinical question is whether a cyst was already present before HRT started and whether it changes in size during treatment.

When Should You Be Concerned About an Ovarian Cyst?

Most ovarian cysts cause no symptoms at all. When symptoms do occur, they typically include pelvic pain, bloating, or a feeling of fullness. Severe pain, especially sudden and sharp, can signal a ruptured cyst or ovarian torsion — a medical emergency.

If you are on HRT and develop new pelvic pain, do not assume it is the HRT. Seek evaluation. An ultrasound can determine the cyst’s size, shape, and internal structure. Simple cysts — thin-walled and fluid-filled — are almost always benign. Complex cysts with solid components or irregular borders require more investigation.

Regular pelvic exams and ultrasounds are not routinely required for all women on HRT. However, if you have a history of ovarian cysts, your clinician may recommend a baseline ultrasound before starting HRT and a follow-up scan within six to twelve months.

Does HRT Increase Ovarian Cancer Risk?

This is a separate question from cyst formation, but it often comes up together. The evidence on HRT and ovarian cancer is more established than the evidence on cysts. Long-term use of estrogen-only therapy — typically more than five years — is associated with a small increased risk of ovarian cancer. Combined HRT carries a smaller elevation in risk, and some studies show no increase at all.

The absolute risk is low. For most women, the number of additional ovarian cancer cases attributable to HRT is small. The decision to use HRT should weigh this risk against the benefits for menopause symptom relief and bone health. This is a personal decision that should be made with your clinician.

It is important to understand that a benign ovarian cyst is not a precursor to ovarian cancer. The vast majority of cysts are harmless, and having a cyst does not meaningfully change your cancer risk.

Practical Guidance for Women on HRT

If you are considering HRT or currently taking it, here is what you should know:

• Tell your clinician about any history of ovarian cysts before starting HRT
• Report new pelvic pain, bloating, or pressure promptly
• Do not stop HRT on your own if you develop a cyst — discuss it with your clinician first
• Ask whether a baseline pelvic ultrasound is appropriate for your situation
• Understand that most cysts found on ultrasound are benign and require no treatment

There is no evidence that HRT causes ovarian cysts to grow rapidly or rupture more frequently. The available research does not support the idea that HRT worsens outcomes for women with simple ovarian cysts.

If you have a complex cyst — one with solid areas, septations, or irregular walls — the management is different. Complex cysts require careful evaluation regardless of HRT use. Your clinician may recommend surgical removal or close monitoring with repeat ultrasounds, depending on the cyst’s characteristics.

Alternatives to HRT for Menopause Symptoms

For women who are concerned about ovarian cysts or who cannot take HRT for other reasons, non-hormonal options exist. These include certain antidepressant medications at low doses, gabapentin, and clonidine for hot flashes. Cognitive behavioral therapy has also shown benefit for sleep disturbances and mood changes during menopause.

Lifestyle measures — layered clothing, cooling strategies, regular exercise, and avoiding triggers like caffeine and alcohol — can reduce symptom burden. Vaginal moisturizers and lubricants address vaginal dryness without systemic hormones.

These alternatives are generally less effective than HRT for severe symptoms, but they are reasonable options for women who prefer to avoid hormones entirely.